论文部分内容阅读
血清唾液酸(Serumsialieacid)简称SA.SA在血清中以糖结合SA和脂结合SA两种形式存在,SA代谢异常,脱落进入体液致使体液中SA含量增高.临床资料表明血清唾液酸与恶件肿瘤及其生长程度有密切关系,特别是原发性肝癌患者血清总SA和脂结合SA含量显著升高,因此.它是一个有效的肿瘤标志物、我们实验室自1992年以来检测30例原发性肝癌患者,另外还检测55例乙型肝炎及10例HBsAg携带者,15例健康人做为对照,其结果是各型肝炎SA阳性率不同,特别是肝癌患者SA水平明显增高.血清唾液酸水平可做为原发性肝癌诊断标准,以往原发性肝癌的诊断主要靠肝活检、肝扫描及AFP的检测等,但是,这些还不能足以鉴别原发性肝癌,本文对30例肝癌患者进行血清SA的检测结果表明,原发性肝癌
Serum sialic acid (SAM) is abbreviated as SA. SA exists in the serum in the form of sugar-binding SA and lipid-binding SA. Abnormal SA metabolism results in increased SA content in body fluids as a result of shedding into body fluids. Clinical data indicate serum sialic acid and malignancy. It is closely related to its degree of growth, especially serum levels of total SA and lipid-associated SA in patients with primary liver cancer. Therefore, it is an effective tumor marker. Our laboratory has detected 30 cases of primary tumor since 1992. In patients with hepatocellular carcinoma, 55 cases of hepatitis B and 10 cases of HBsAg carriers were also tested. Fifteen healthy people were used as controls. The result was that the positive rate of SA in different types of hepatitis was different. In particular, the level of SA in liver cancer patients was significantly higher. Serum sialic acid The level can be used as the diagnostic criteria for primary liver cancer. In the past, the diagnosis of primary liver cancer relied mainly on liver biopsy, liver scan, and AFP detection. However, these were not enough to identify primary liver cancer. This article was conducted on 30 patients with liver cancer. Serum SA test results show that primary liver cancer